Brain metastases from renal cell carcinoma treatment [Neurosurgerypaedia]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Brain metastases from renal cell carcinoma treatment ======

{{rss>https://pubmed.ncbi.nlm.nih.gov/rss/search/1NEk0yW-MVyubnb6xKBtOCbjIiMO5lmZCKh-boEj9l7ztm5E--/?limit=15&utm_campaign=pubmed-2&fc=20240418065301}}


Treatment typically involves a combination of surgery, radiation therapy, chemotherapy, targeted therapy, and supportive care aimed at managing symptoms and controlling the progression of the disease.
----
Clinical trials are currently investigating the role of targeted therapy and immune checkpoint inhibitor combinations in treating brain metastases and decreasing intracranial disease progression
((Hasanov E, Jonasch E. Management of Brain Metastases in Metastatic Renal Cell Carcinoma. Hematol Oncol Clin North Am. 2023 Oct;37(5):1005-1014. doi: 10.1016/j.hoc.2023.04.020. Epub 2023 Jun 1. PMID: 37270383.))
----
Patients with brain metastases from renal cell carcinoma (RCC) may benefit from systemic combination immunotherapy as well as brain-directed local therapies, according to data presented during the 2023 ASCO Genitourinary Cancers Symposium 
((https://meetings.asco.org/abstracts-presentations/217345))